Summary
Commonly reported side effects of thalidomide include: asthenia. Continue reading for a comprehensive list of adverse effects.
Applies to thalidomide: oral capsule.
Warning
Oral route (Capsule)
Thalidomide can cause severe birth defects or embryofetal death, even with 1 dose, if taken during pregnancy. Thalidomide distribution is restricted through the THALOMID REMS(TM) program (formerly known as the S.T.E.P.S.® program). The use of thalidomide in multiple myeloma patients results in an increased risk of VTE , such as DVT and pulmonary embolism. Coadministration of dexamethasone increases this risk. Monitor for thromboembolism and consider thromboprophylaxis for individualized cases.
Serious side effects of Thalidomide
Along with its needed effects, thalidomide may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking thalidomide:
More common
- Anxiety
- black, tarry stools
- chest pain
- chills
- confusion
- cough
- dizziness or lightheadedness
- dry mouth
- fainting
- fast heartbeat
- fever
- irregular heartbeat
- irritability
- loss of taste
- lower back or side pain
- mood or mental changes
- muscle cramps in the hands, arms, feet, legs, or face
- muscle weakness
- nervousness
- numbness and tingling around the mouth, fingertips, or feet
- pain in the chest, groin, or legs, especially the calves
- pain, redness, or swelling in the arm or leg
- painful or difficult urination
- pale skin
- peeling and loosening of the skin
- restlessness
- seizures
- severe, sudden headache
- skin rash
- shakiness in the legs, arms, hands, or feet
- slurred speech
- sore throat
- sores, ulcers, or white spots in the mouth or on the lips
- stomach cramps
- sudden, unexplained shortness of breath
- sudden loss of coordination
- sudden, severe weakness or numbness in the arm or leg
- swollen glands
- tenderness, pain, swelling, warmth, skin discoloration, and prominent superficial veins over the affected area
- tingling, burning, numbness, or pain in the hands, arms, feet, or legs
- trembling or shaking of hands or feet
- trouble sleeping
- troubled breathing
- unusual bleeding or bruising
- unusual tiredness or weakness
- vision changes
Rare
- Blood in the urine
- decreased urination
Incidence not known
- Bleeding gums
- blistering of the skin
- blood in the stools
- difficulty with speaking
- inability to move the arms, legs, or facial muscles
- inability to speak
- itching skin
- muscle jerking of the arms and legs
- pinpoint red spots on the skin
- red skin lesions, often with a purple center
- red, irritated eyes
- slow speech
- sudden loss of consciousness
Other side effects of Thalidomide
Some side effects of thalidomide may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- Constipation
- dry skin
- diarrhea
- dizziness
- drowsiness
- loss of appetite
- nausea
- stomach pain
- weight changes
Less common
- Headache
- increased appetite
For Healthcare Professionals
Applies to thalidomide: oral capsule.
General
In uncontrolled studies with HIV-seropositive patients, there were reports of adverse events (e.g., increased HIV viral load, decreased CD4 count, AIDS) that were not reported in other patient populations; consult the manufacturer product information.[Ref]
Metabolic
Very common (10% or more): Hypocalcemia (95%), anorexia (28%), weight loss (23%), weight gain (22%)
Common (1% to 10%): Hypokalemia, hyperlipidemia
Rare (less than 0.1%): Increased appetite
Frequency not reported: Increased appetite, electrolyte abnormalities, hyperkalemia, hypocalcemia, hypoproteinemia, increased lactate dehydrogenase (LDH), decreased phosphorus
Postmarketing reports: Tumor lysis syndrome, hypercalcemia, hyponatremia, hypomagnesemia[Ref]
Other
Very common (10% or more): Fatigue (79%), edema (56%), peripheral edema (34%), asthenia (24%), pyrexia/fever (24%)
Common (1% to 10%): Accidental injury, chills, infection, pain, malaise, weakness, lethargy
Frequency not reported: Tinnitus, palpable spleen
Postmarketing reports: Sepsis, septic shock, hearing impairment/deafness, hangover effect[Ref]
Gastrointestinal
Very common (10% or more): Constipation (55%), nausea (28%), diarrhea (18.7%), dry mouth (12%), oral moniliasis (11.1%), dyspepsia (11%)
Common (1% to 10%): Abdominal pain, vomiting, flatulence
Uncommon (0.1% to 1%): Diverticular perforation, peritonitis
Very rare (less than 0.01%): Intestinal obstruction
Frequency not reported: Enlarged abdomen, eructation
Postmarketing reports: Gastrointestinal (GI) perforation, GI hemorrhage, pancreatitis, bile duct obstruction, stomach ulcer, aphthous stomatitis[Ref]
Nervous system
Very common (10% or more): Sensory neuropathy (54%), drowsiness/somnolence/sedation (37.5%), tremor (26%), dizziness/lightheadedness (23%), motor neuropathy (22%), headache (18.7%), depressed level of consciousness (16%), paresthesia (15.6%), sensory peripheral neuropathy (10%)
Common (1% to 10%): Cerebrovascular accident/event, syncope, vertigo, abnormal coordination, transient ischemic event, ataxia, amnesia, causalgia, circumoral paresthesia, hyperesthesia, dysesthesia
Frequency not reported: Neuritis, peripheral neuritis, neuralgia, hypertonia
Postmarketing reports: Seizures, convulsions, Parkinson's disease/worsening of Parkinson's disease symptoms, posterior reversible encephalopathy syndrome (PRES)/reversible posterior leukoencephalopathy syndrome (RPLS), stupor, stroke, carpal tunnel, Raynaud's syndrome, migraine, foot drop[Ref]
Hematologic
Very common (10% or more): Neutropenia (42.7%), decreased leukocytes (35%), decreased neutrophils (31%), leukopenia (25.8%), anemia (13.7%), lymphadenopathy (12.5%), lymphopenia (12.1%), thrombocytopenia (11.3%)
Very rare (less than 0.01%): Eosinophilia
Frequency not reported: Increased/decreased platelet count, decreased erythrocyte sedimentation rate (ESR), granulocytopenia, hypochromic anemia, leukocytosis, elevated mean corpuscular volume (MCV), abnormal red blood cell (RBC) count
Postmarketing reports: Febrile neutropenia, pancytopenia, decreased white blood cell (WBC) count, prothrombin time changes, lymphedema[Ref]
Respiratory
Very common (10% or more): Dyspnea (42%), pneumonia (15%)
Common (1% to 10%): Bronchopneumonia, pulmonary embolism, pharyngitis, sinusitis, interstitial lung disease
Uncommon (0.1% to 1%): Bronchitis
Very rare (less than 0.01%): Bronchospasm
Frequency not reported: Cough, emphysema, epistaxis, rales, upper respiratory infection, voice alteration[Ref]
Musculoskeletal
Very common (10% or more): Muscle weakness (40%), myalgia (17%), arthralgia (13%)
Common (1% to 10%): Muscle cramps
Frequency not reported: Upper extremity pain, arthritis, bone tenderness, joint disorder, leg cramps, myasthenia, periosteal disorder[Ref]
Dermatologic
Very common (10% or more): Rash/desquamation (30%), rash (25%), dry skin (21%), maculopapular rash (18.7%), sweating (12.5%), acne (11.1%)
Common (1% to 10%): Fungal dermatitis, nail disorder, pruritus, toxic skin eruption, urticaria
Very rare (less than 0.01%): Severe skin reactions (Stevens-Johnson Syndrome, toxic epidermal necrolysis), facial edema, photosensitivity, alopecia, eczematous rash, exfoliative dermatitis, ichthyosis, perifollicular thickening, skin necrosis, seborrhea, sweating, vesiculobullous rash
Postmarketing reports: Erythema multiforme, erythema nodosum, purpura, petechiae[Ref]
Psychiatric
Very common (10% or more): Confusion (28%), anxiety/agitation (26%), depression (10%)
Common (1% to 10%): Insomnia, nervousness, abnormal thinking, euphoria, impotence, altered mood/mood changes/mental status changes
Very rare (less than 0.01%): Decreased libido
Frequency not reported: Psychosis
Postmarketing reports: Sexual dysfunction, suicide attempts[Ref]
Cardiovascular
Very common (10% or more): Thrombosis/embolism (22%), deep vein thrombosis (13%)
Common (1% to 10%): Atrial fibrillation, myocardial ischemia/infarction, bradycardia, cardiac failure, hypotension
Uncommon (0.1% to 1%): Orthostatic hypotension
Rare (less than 0.1%): Tachycardia, cardiac arrhythmia
Frequency not reported: Hypertension, peripheral vascular disorder, vasodilation, cyanosis
Postmarketing reports: Atrioventricular block, pulmonary hypertension, sick sinus syndrome, electrocardiogram (ECG) abnormalities[Ref]
Endocrine
Very common (10% or more): Hyperglycemia (15%)
Very rare (less than 0.01%): Hypothyroidism, menstruation abnormalities, amenorrhea
Frequency not reported: Diabetes, inappropriate antidiuretic hormone (ADH)
Postmarketing reports: Myxedema, galactorrhea, gynecomastia[Ref]
Hepatic
Very common (10% or more): Abnormal bilirubin level (14%), increased SGOT (12.5%)
Common (1% to 10%): Abnormal liver function tests
Frequency not reported: Enlarged liver, bilirubinemia, increased SGPT
Postmarketing reports: Increased alkaline phosphatase[Ref]
Genitourinary
Very common (10% or more): Hematuria (11.1%)
Common (1% to 10%): Albuminuria
Frequency not reported: Hyperuricemia, proteinuria, pyuria, urinary frequency, orchitis
Postmarketing reports: Oliguria, enuresis, metrorrhagia[Ref]
Ocular
Common (1% to 10%): Blurred vision
Frequency not reported: Amblyopia, dry eye, eye pain
Postmarketing reports: Diplopia, nystagmus[Ref]
Hypersensitivity
Frequency not reported: Hypersensitivity/allergic reactions, angioedema[Ref]
Immunologic
Frequency not reported: Viral reactivation (herpes zoster, hepatitis B, cytomegalovirus), increased HIV viral load/RNA levels, amyloidosis
Postmarketing reports: Viral infections[Ref]
Oncologic
Frequency not reported: Acute myeloid leukemia, myelodysplastic syndromes
Postmarketing reports: Chronic myelogenous leukemia, nodular sclerosing Hodgkin's disease, erythroleukemia[Ref]
Renal
Frequency not reported: Increased BUN, increased creatinine
Postmarketing reports: Renal failure, acute renal failure[Ref]